Research record R-044Commercially available

Paro

By PARO Robots (Intelligent System Co.) · Japan · announced November 2001

The therapeutic baby seal with two decades of peer-reviewed evidence and an FDA medical-device classification.

Curated overlap

This robot has a deeper field-guide dossier.

Use the curated dossier for claim-level citations, regional offers, ownership context, and the current editorial assessment.

Continue to the curated dossier
Research summary

What the record says.

Paro is a robotic harp seal pup developed by Takanori Shibata at Japan's AIST, in continuous production since the mid-2000s and in clinical use worldwide. It responds to touch, voice and light with movement and seal sounds, and is used in dementia care to reduce agitation and support engagement, filling the role of animal therapy where live animals are impractical.

It is the most-studied companion robot ever made, with more than 30 peer-reviewed studies, and was classified as a Class II medical device by the US FDA in 2009. A unit costs around $6,100, with leasing around $169 per month through distributors; the eighth-generation design changed little because it did not need to.

Paro chose a seal deliberately: unfamiliar enough that users hold no expectations a robot would fail to meet. Twenty years later, the entire companion-robot industry is still relearning that lesson.

Delivery evidence

Announcement is not arrival.

Commercially deployed

Thousands of units in care facilities worldwide since the 2000s

Capability ledger

What has actually been shown?

2 material claims are separated by evidence setting and human involvement. The strongest recorded signal is Commercially deployed; it does not automatically transfer to every row.

01
elder care

Reduces agitation and supports engagement in dementia care

30+ peer-reviewed studies; FDA Class II classification

Independently testedVerified July 2026
Control mode
Autonomous
Human intervention
Facilitated by care staff
02
entertainment

Soothing animal-companion play

Owner verifiedVerified July 2026
Control mode
Autonomous
Human intervention
None
Body & movement

Hardware record.

Height
16 cm
Weight
2.5 kg
Locomotion
Stationary; moves head, flippers and tail
Payload
None
Runtime
About 1.5 hours active per charge
Charging
Charger styled as a pacifier
Top speed
Not applicable
Degrees of freedom
7
Hands
None
Face / expression
Large eyes with lids; seal expressions
Sensors
Touch-sensitive fur surface, whisker sensors, light, sound direction, temperature, posture
Intelligence & control

Software record.

AI platform
Behavioral AI tuned for therapeutic response; no cloud, no LLM
Voice
Seal vocalizations only; recognizes its name and repeated words
Languages
Responds to tone and repetition rather than language
Visual recognition
Light sensing only
Memory
Learns preferred interactions and its given name
Processing
Fully local; no connectivity
Autonomous abilities
Fully autonomous behavior
Teleoperation
None
Software updates
None needed; hardware service via distributors
Developer access
None
Privacy & safety

Who can see, hear, or take control?

Recording storage
None; no connectivity and no recording
Remote operation possible
No documented remote operation
Teleoperation disclosure
Not applicable
Camera / microphone controls
Power switch
Data deletion
Nothing to delete
Account required
No
Emergency stop
Power switch; soft and harmless
Children and pets
Extremely safe; used with vulnerable populations
Security updates
Not applicable (offline)
Lifecycle record

Status history.

  1. Research project

    AIST research prototypes

  2. Commercially available

    Commercial sales begin in Japan

  3. Commercially available

    US FDA Class II classification; international clinical adoption

Source register

3 linked sources.

These sources support the research record as a whole. Unlike the curated dossiers, this imported record does not yet map every claim to a stable source ID.

  1. S01PARO Robots · 2026Paro official site
  2. S02Robotomated · 2026Paro therapeutic pricing and status
  3. S03Wikipedia · 2026Paro overview and FDA classification